Management of Left Ventricular Aneurysm

Introduction to Left Ventricular Aneurysm Management

For patients with left ventricular aneurysm, oral anticoagulation with warfarin (target INR 2.0-3.0) is recommended for at least 3 months if a thrombus is present, followed by long-term antiplatelet therapy with aspirin (75-100 mg daily) after thrombus resolution, as recommended by the American Heart Association and American College of Cardiology 1, 2, 3, 4
The presence of a left ventricular thrombus increases the risk of systemic embolism, and anticoagulation decisions should be based on factors such as thrombus presence, ejection fraction, aneurysm location, and additional risk factors like atrial fibrillation or prior embolism, according to the American Heart Association and European Society of Cardiology 1, 2

Initial anticoagulation with warfarin (target INR 2.0-3.0) for at least 3 months is recommended for patients with left ventricular aneurysm and thrombus, with regular echocardiography to confirm thrombus resolution and guide anticoagulation therapy, as recommended by the American College of Cardiology and American Heart Association 1, 2
Periodic INR monitoring is necessary to maintain a therapeutic range and minimize bleeding risk, according to the American Heart Association 1, 2

Patients with coexisting conditions such as atrial fibrillation or mechanical valves require continued long-term anticoagulation, as per guidelines from the American College of Chest Physicians and American Heart Association 5, 3, 4
The presence of severe left ventricular dysfunction (ejection fraction <40%), history of systemic embolism, or persistent anteroapical wall motion abnormality may influence anticoagulation decisions, according to the European Society of Cardiology and American College of Cardiology 1, 2, 3, 4

Anticoagulation therapy with warfarin should be initiated for a minimum of 3 months in patients with left ventricular thrombus, with a target INR of 2.0-3.0, followed by antiplatelet therapy with aspirin (75-100 mg daily) after thrombus resolution, as recommended by the American Heart Association and American College of Cardiology 1, 2, 3, 4
The strength of evidence for anticoagulation therapy in patients with left ventricular aneurysm and thrombus is moderate to high, with a recommendation for anticoagulation in patients with high-risk features, according to the American College of Cardiology and American Heart Association 1, 2, 3, 4
Aspirin 75-100 mg daily should be continued indefinitely in patients with a history of LV thrombus after resolution, as part of long-term antithrombotic management, with consideration of low-dose aspirin (81 mg) to minimize bleeding risk, according to the American College of Cardiology and American College of Chest Physicians 3, 4

Regular cardiac follow-up with reassessment of LV function is recommended, with periodic echocardiography to ensure continued absence of thrombus, according to the American College of Cardiology and American Heart Association 3
Patients should be monitored for signs of bleeding complications and assessed for symptoms of thromboembolism (stroke, TIA, peripheral embolism), with consideration of dual antiplatelet therapy guidelines for patients with coronary stenting, according to the American College of Cardiology and American Heart Association 3
Patients with high recurrence risk factors, such as severe LV dysfunction (EF <40%), persistent anteroapical wall motion abnormality, or history of systemic embolism, may benefit from extended anticoagulation with warfarin (target INR 2.0-3.0) plus aspirin, according to the American College of Cardiology and American College of Chest Physicians 4

In patients with high bleeding risk, low-dose aspirin (75-81 mg) is preferred, according to the American College of Cardiology and American Heart Association 3
In patients with thrombocytopenia, aspirin can generally be continued unless platelet count falls below a certain threshold or active bleeding occurs, according to the American College of Cardiology and American Heart Association 6